Swiss Biotech Report reporting record turnover
The Swiss biotech sector proved robust growth in 2023. Revenues in 2023 increased by CHF500m to CHF7bn, capital investment decreased to CHF2bn compared to 2021 (CHF3.4bn) but was higher than in 2022 (CHF1.3bn). The Swiss Biotech Report 2024 commissioned by …